Molecular dichotomy of mucinous carcinoma defined by the presence of solid papillary carcinoma components: an integrative transcriptomic analysis
Histopathology · 2026-12 · 89 (6) · 999-1010
DOI: 10.1111/his.70253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, online erschienen am 31.07.2026. Verfasst von Yuki Hara und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Hauptthemen laut MEDLINE: Carcinoma, Papillary, Adenocarcinoma, Mucinous, Breast Neoplasms. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Aims
Mucinous carcinoma (MC) of the breast is a relatively homogeneous entity; however, it may occasionally display invasive micropapillary features. A subset of cases also show histological overlap with solid papillary carcinoma (SPC), suggesting potential biological divergence. In this study, we performed an integrative transcriptomic analysis of MC using The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) cohorts to investigate the molecular significance of SPC‐associated features. Methods and results MC cases were stratified into those with SPC components (MC‐SPC) and those without SPC components (MC‐OTHER) based on histological assessment in the TCGA cohort and transcriptomic scoring in the METABRIC cohort. In TCGA cohort, MC‐SPC was enriched for neurotransmission and synaptic signalling pathways, whereas MC‐OTHER demonstrated upregulation of extracellular matrix organization and cell adhesion. These findings were replicated in the METABRIC cohort by using a projected SPC‐like gene signature. After adjusting for immune‐related confounding factors, distinct immune and metabolic profiles emerged: OTHER‐like MCs were associated with increased immune signalling, whereas SPC‐like MCs exhibited enhanced mitochondrial and biosynthetic activities.
Conclusions
These findings indicate that MC comprises at least two biologically and histologically distinct variants defined by SPC‐associated features, providing a framework for refined classification and development of subtype‐specific therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgical Oncology, Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Breast Center, Nagasaki University Hospital, Nagasaki, Japan.
- Department of Diagnostic Pathology, Nagasaki University Hospital, Nagasaki, Japan.
- Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
- Division of Digestive Surgery and Transplantology, Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
ORCID-Profile: Yuki Hara, Rin Yamaguchi, Masanori Oshi, Ryota Otsubo, Shintaro Urakawa, Aya Tanaka, Momoko Akashi, Sayaka Kuba, Megumi Matsumoto, Susumu Eguchi, Keitaro Matsumoto
Zitieren
APA
Hara, Y., Yamaguchi, R., Oshi, M., Otsubo, R., Urakawa, S., Tanaka, A., Akashi, M., Kuba, S., Matsumoto, M., Eguchi, S., & Matsumoto, K. (2026). Molecular dichotomy of mucinous carcinoma defined by the presence of solid papillary carcinoma components: an integrative transcriptomic analysis. Histopathology, 89(6), 999-1010. https://doi.org/10.1111/his.70253
Vancouver
Hara Y, Yamaguchi R, Oshi M, Otsubo R, Urakawa S, Tanaka A, et al. Molecular dichotomy of mucinous carcinoma defined by the presence of solid papillary carcinoma components: an integrative transcriptomic analysis. Histopathology. 2026;89(6):999-1010. doi:10.1111/his.70253
BibTeX
@article{Hara2026,
author = {Hara, Yuki and Yamaguchi, Rin and Oshi, Masanori and Otsubo, Ryota and Urakawa, Shintaro and Tanaka, Aya and Akashi, Momoko and Kuba, Sayaka and Matsumoto, Megumi and Eguchi, Susumu and Matsumoto, Keitaro},
title = {Molecular dichotomy of mucinous carcinoma defined by the presence of solid papillary carcinoma components: an integrative transcriptomic analysis},
journal = {Histopathology},
year = {2026},
volume = {89},
number = {6},
pages = {999--1010},
doi = {10.1111/his.70253}
}
EUVIMED